Douglas Reed

Douglas Reed

Director/Board Member chez Viamet Pharmaceuticals Corp.

70 ans
Health Technology
Finance
Consumer Services

Profil

Douglas W.
Reed
is currently the Chairman at Innocrin Pharmaceuticals Holdings LLC since 2014.
He is also the Director at Viamet Pharmaceuticals, Inc. since 2007, the Director at Contego Medical, Inc., the Director at Viamet Pharmaceuticals Corp.
since 2011, the Director at Southeast BIO since 2009, the Director at Innocrin Pharmaceuticals, Inc., the Director at Standard Bariatrics, Inc., the Director at Qpex Biopharma, Inc., the General Partner at Hatteras Venture Affiliates III LP, and the General Partner at Hatteras Venture Partners since 2007.
In the past, Dr. Reed worked as the Director at Star Equity Holdings, Inc. from 2000 to 2009.
He was also the Director at PhaseBio Pharmaceuticals, Inc. from 2007 to 2009, the Independent Director at TetraLogic Pharmaceuticals Corp.
from 2010 to 2016, and the Director at Gilead Connecticut, Inc. from 2001 to 2010.
Additionally, he served as the Vice President-Business Development at NPS Pharmaceuticals, Inc. in 1996 and 1997, and at GelTex Pharmaceuticals, Inc. in 1998 and 1999.
He was a Principal at GSK Equity Investments Ltd.
from 1989 to 1995, and an Assistant Professor at the University of Washington in 1983.
Dr. Reed obtained his undergraduate and doctorate degrees from the University of Missouri-Kansas City in 1977 and 1978, respectively.
He also holds an MBA from The Wharton School of the University of Pennsylvania, which he received in 1989.

Postes actifs de Douglas Reed

SociétésPosteDébut
Director/Board Member -
Chairman 01/01/2014
Director/Board Member -
Director/Board Member -
Southeast BIO Director/Board Member 01/01/2009
Director/Board Member 01/05/2007
Hatteras Venture Affiliates III LP Corporate Officer/Principal -
Director/Board Member 01/12/2011
Private Equity Investor 01/01/2007
░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
Tous les postes actifs de Douglas Reed

Anciens postes connus de Douglas Reed

SociétésPosteFin
░░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
Voir l'expérience en détail de Douglas Reed

Formation de Douglas Reed

University of Missouri-Kansas City Doctorate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Douglas Reed

Relations

100 +

Relations au 1er degré

27

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
STAR EQUITY HOLDINGS, INC.

Health Technology

PHASEBIO PHARMACEUTICALS, INC.

Health Technology

TETRALOGIC PHARMACEUTICALS CORPORATION

Health Technology

Entreprise privées21

Health Technology

Health Technology

Health Technology

Hatteras Venture Affiliates III LP

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Finance

Health Technology

Finance

Southeast BIO

Finance

Commercial Services

Finance

Health Technology

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Douglas Reed